Loading...
Drug Pricing Investigation--Lost Savings: How Prohibiting Medicare Negotiation Has Cost Taxpayers
House Committee on Oversight and Reform
House Committee on Oversight and Reform
Citations
Altmetric:
Abstract
The House Committee on Oversight and Reform issued a Staff Report on expensive prescription drugs sold to Medicare by ten of the largest drug manufacturers, revealing tactics that keep prices high and emphasizing the need for direct Medicare negotiation with these companies.
Date
2021-09-22
Document Type
House Staff Report
Serial Number
Document Length
26 pages
Congress
117
Relation
DOI
Keywords
Staff Reports, House
PAP Major Code
3: Health
PAP Minor Code
335: Prescription Drug Coverage and Costs
Cited Hearings
• House Committee on Oversight and Reform, hearing on "Unsustainable Drug Prices: Testimony from the CEOs (Parts I)," 116th Cong., H.Hrg. 116-122, (2020, September 30)